- Home
- UONE vs GNLX Comparison
UONE vs GNLX Comparison
Compare UONE & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- GNLX
- Stock Information
- Founded
- UONE 1980
- GNLX 2001
- Country
- UONE United States
- GNLX United States
- Employees
- UONE N/A
- GNLX N/A
- Industry
- UONE Broadcasting
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- UONE Consumer Discretionary
- GNLX Health Care
- Exchange
- UONE Nasdaq
- GNLX Nasdaq
- Market Cap
- UONE 69.5M
- GNLX 81.5M
- IPO Year
- UONE N/A
- GNLX 2023
- Fundamental
- Price
- UONE $1.46
- GNLX $2.46
- Analyst Decision
- UONE
- GNLX Strong Buy
- Analyst Count
- UONE 0
- GNLX 4
- Target Price
- UONE N/A
- GNLX $18.25
- AVG Volume (30 Days)
- UONE 24.5K
- GNLX 80.9K
- Earning Date
- UONE 11-12-2024
- GNLX 11-14-2024
- Dividend Yield
- UONE N/A
- GNLX N/A
- EPS Growth
- UONE N/A
- GNLX N/A
- EPS
- UONE N/A
- GNLX N/A
- Revenue
- UONE $452,891,000.00
- GNLX $8,000.00
- Revenue This Year
- UONE N/A
- GNLX N/A
- Revenue Next Year
- UONE N/A
- GNLX N/A
- P/E Ratio
- UONE N/A
- GNLX N/A
- Revenue Growth
- UONE N/A
- GNLX N/A
- 52 Week Low
- UONE $1.23
- GNLX $1.60
- 52 Week High
- UONE $4.10
- GNLX $12.59
- Technical
- Relative Strength Index (RSI)
- UONE 43.18
- GNLX 48.80
- Support Level
- UONE $1.47
- GNLX $2.25
- Resistance Level
- UONE $1.64
- GNLX $2.57
- Average True Range (ATR)
- UONE 0.09
- GNLX 0.19
- MACD
- UONE -0.01
- GNLX 0.01
- Stochastic Oscillator
- UONE 4.17
- GNLX 41.18
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.